Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 56.20% | -18.48% | -23.52% | 12.94% | 39.68% |
| Total Depreciation and Amortization | 128.30% | 19.14% | -4.63% | -39.54% | -54.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.17% | 1.53% | 50.48% | -26.79% | -15.65% |
| Change in Net Operating Assets | -123.44% | 155.29% | 4.72% | 402.42% | 44.88% |
| Cash from Operations | -9,765.63% | 101.65% | -1.52% | 58.22% | 52.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 115.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -52.40% | -81.52% |
| Total Debt Repaid | -- | 81.80% | -140.10% | -243.64% | 32.17% |
| Issuance of Common Stock | -- | -94.65% | 53.72% | -46.77% | -55.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,821.09% | -107.50% | 6.29% | -61.90% | -55.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 372.59% | 41.30% | 23.84% | 14.20% | -826.32% |